OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J. Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 1, pp. 145-159
Open Access | Times Cited: 25

Showing 25 citing articles:

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3

Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer
Simon J. Cleary, Longhui Qiu, Yurim Seo, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 5
Open Access | Times Cited: 2

Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 12

Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
Emily Wolf, Guilherme Sacchi de Camargo Correia, Shenduo Li, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 128-128
Open Access | Times Cited: 1

Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
Lijun Li, Haihong Pu, Xiaoxin Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104683-104683
Closed Access | Times Cited: 1

Cytokine Signalling in Formation of Neutrophil Extracellular Traps: Implications for Health and Diseases
Haritha Manoj, Sarah Michael Gomes, Pooja Yedehalli Thimmappa, et al.
Cytokine & Growth Factor Reviews (2024)
Open Access | Times Cited: 7

Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance
Shauna McClelland, Pamela Maxwell, Cristina Branco, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2797-2797
Open Access | Times Cited: 5

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
Felipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access

A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access

Smart materials in pharmacological drug development: Neutrophils and its constituents for drug delivery and consequent antitumor effects
Shengjie Cai, Xuehan Wei, Qian Li, et al.
Molecular Immunology (2025) Vol. 183, pp. 18-32
Closed Access

Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer
Benjamin Christopher, Lena Golick, Ashton Basar, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 645-645
Open Access

KRAS mutations in colorectal cancer: impacts on tumor microenvironment and therapeutic implications
Alireza S. Emami, Pouya Mahdavi Sharif, Nima Rezaei
Expert Opinion on Therapeutic Targets (2025), pp. 1-23
Closed Access

Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer
Qi Xie, Xiaolin Liu, Rengyun Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
Hao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Cancer Letters (2024) Vol. 611, pp. 217417-217417
Closed Access | Times Cited: 3

Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1
Max E. Huber, Silas Wurnig, Aurélien F. A. Moumbock, et al.
ChemMedChem (2024) Vol. 19, Iss. 20
Open Access | Times Cited: 2

Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2

Senescent neutrophils: a hidden role in cancer progression
Ryan N. Rys, Arianna Calcinotto
Trends in Cell Biology (2024)
Open Access | Times Cited: 1

Multifaceted roles of neutrophils in tumor microenvironment
Xue‐Yin Pan, Qiang Wang, Beicheng Sun
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189231-189231
Closed Access | Times Cited: 1

Future Landscape in High-risk Prostate Cancer and Metastatic Prostate Cancer
Harshit Garg, Dharam Kaushik, Michael A. Liss
UroCancer Clinics of India . (2024) Vol. 2, Iss. 1, pp. 37-44
Open Access

The CXCR2 chemokine receptor: A new target for gastric cancer therapy
Wenyan Kang, Chengkun Wang, Minhui Wang, et al.
Cytokine (2024) Vol. 181, pp. 156675-156675
Closed Access

A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor
Wenyan Kang, Chengkun Wang, Minhui Wang, et al.
Journal of Molecular Histology (2024)
Closed Access

Squaric acid derivatives with cytotoxic activity- a review
Georgi Tirolski, Georgi Momekov, Emiliya Cherneva
Chemico-Biological Interactions (2024), pp. 111344-111344
Open Access

Antimitotic chemotherapy promotes tumor NF-kB secretory phenotype and immunosuppressive CXCR2+ neutrophils chemotaxis in triple-negative breast cancers
Florian Chocteau, Fabien Gautier, Vanessa Josso, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Page 1

Scroll to top